Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Radiation Dose Hypofractionation × Clear all

NCT05292417 2022-03-31

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms